BioLineRx BLRX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 2.77 | -3,386 | -1 | |||
| 2025Q3 | 3.78 | 0 | -2,207 | -1 | ||
| 2025Q2 | 4.57 | 0 | -2,303 | -4 | ||
| 2025Q1 | 2.96 | 0 | -2,391 | 5 | ||
| 2024Q4 | 8.56 | -3,170 | -3 | |||
| 2024Q3 | 21.44 | 0 | -5,387 | -6 | ||
| 2024Q2 | 22.8 | 0 | -5,773 | 0 | ||
| 2024Q1 | 44.8 | 0 | -4,822 | -1 | ||
| 2023Q4 | 62.8 | -11,864 | -14 | |||
| 2023Q3 | 72.8 | -12 | -12,357 | -16 | ||
| 2023Q2 | 63.8 | -12 | -9,915 | -19 | ||
| 2023Q1 | 35.46 | -6 | -8,856 | -12 | ||
| 2022Q4 | 23.6 | 0 | -8,398 | -6 | ||
| 2022Q3 | 37 | -6 | -7,078 | -7 | ||
| 2022Q2 | 51.2 | -6 | -7,602 | -7 | ||
| 2022Q1 | 68.4 | -6 | -6,079 | -5 | ||
| 2021Q4 | 81.6 | -6,598 | -4 | |||
| 2021Q3 | 110 | -6 | -6,217 | -6 | ||
| 2021Q2 | 112.4 | -6 | -6,513 | -7 | ||
| 2021Q1 | 111.6 | -12 | -5,449 | -10 |